Unit
- Prevalence and incidence: Heart failure affects approximately 1-2% of the adult population in developed countries, with prevalence rising sharply after age 65. It is a leading cause of hospitalization and readmission among older adults, placing substantial strain on healthcare systems. Global burden is increasing due to aging populations and improved survival from cardiovascular events.
- Risk factors: Major modifiable risk factors include hypertension, diabetes, obesity, smoking, and physical inactivity. Non-modifiable factors comprise age, gender (higher in men), and genetic predisposition. Effective management of these factors can reduce incident heart failure cases by up to 50% in high-risk populations.
- Economic impact: Heart failure accounts for substantial direct costs (hospitalizations, medications, procedures) and indirect costs (lost productivity, caregiver burden). In the United States alone, annual costs exceed $30 billion, with projections to double by 2030. Cost-effective care models emphasize prevention and coordinated management.
- Hospitalization trends: Heart failure is the most common cause of hospitalization in adults over 65. Readmission rates within 30 days approach 25%, prompting value-based reimbursement penalties. Strategies to reduce readmissions include transitional care programs, patient education, and close outpatient follow-up.
- Quality of life: Patients with heart failure experience profound physical limitations, fatigue, dyspnea, and depression. Symptom burden affects daily activities and social participation. Patient-reported outcomes measures are increasingly used to gauge treatment success and guide care planning.
- Public health perspective: Heart failure prevention requires population-level interventions such as blood pressure control, diabetes management, and health literacy campaigns. Public health agencies promote guidelines and registries to monitor progress. Integration of social determinants of health into care models is critical for equity.
- Disparities: Racial and ethnic minorities, particularly African Americans and Hispanics, have higher heart failure incidence and worse outcomes. Socioeconomic factors, access to care, and cultural barriers contribute. Culturally tailored education and community health workers can help close gaps.
- Global perspective: In low- and middle-income countries, heart failure often stems from untreated hypertension, rheumatic heart disease, and infectious causes. Resources for advanced therapies are limited, emphasizing prevention and basic pharmacotherapy. Global collaborations aim to adapt guidelines to local contexts.
Terminology
- Heart failure with preserved ejection fraction (HFpEF)
- A type of heart failure where the left ventricle retains normal pumping ability but is stiff, causing inadequate filling. Common in older adults with comorbidities such as hypertension and diabetes.
- Heart failure with reduced ejection fraction (HFrEF)
- Heart failure characterized by a left ventricular ejection fraction ≤40%, often due to prior myocardial infarction or cardiomyopathy. Responsive to neurohormonal blockade therapy.
- Ejection fraction
- The percentage of blood pumped out of the left ventricle with each contraction. Normal is 50-70%. Values below 40% indicate systolic dysfunction.
Scope of Practice
Role: Heart Failure Case Manager
Within scope:
- Educating patients and families about heart failure warning signs and self-monitoring
- Coordinating referrals to cardiology, nutrition, and social services
- Reviewing medication adherence and side effects during follow-up calls
- Documenting symptom progression and vital signs in electronic health records
Outside scope:
- Adjusting diuretic or ACE inhibitor doses without provider order
- Interpreting echocardiogram results or lab values independently
- Diagnosing heart failure subtype or etiology
- Prescribing or discontinuing heart failure medications
Quick Revision
- Heart failure prevalence rises with age and is a leading cause of hospitalization.
- Modifiable risk factors include hypertension, diabetes, and obesity.
- Economic burden is high, with readmission penalties driving quality initiatives.
- Disparities exist by race, ethnicity, and socioeconomic status.
- Case managers educate, coordinate, and monitor but do not diagnose or adjust medications.